Studies have shown that TWEAK is involved in a variety of inflammatory and autoimmune diseases, such as atherosclerosis, heart failure, the pathogenesis of chronic kidney disease, II type diabetes. Here, TNFSF12 is linked to type 2 diabetes mellitus.